false 0001476963 0001476963 2024-01-08 2024-01-08 0001476963 us-gaap:CommonStockMember 2024-01-08 2024-01-08 0001476963 NHWK:CommonStockPurchaseRightsMember 2024-01-08 2024-01-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): January 8, 2024

 

NightHawk Biosciences, Inc.

(Exact name of registrant as specified in charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

001-35994 26-2844103
(Commission File Number) (IRS Employer Identification No.)

 

627 Davis Drive, Suite 300

Morrisville, North Carolina 27560

(Address of principal executive offices and zip code)

 

(919) 240-7133

(Registrant’s telephone number including area code)

 

N/A

(Former Name and Former Address)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.0002 par value per share NHWK NYSE American LLC
Common Stock Purchase Rights None NYSE American LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨  

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 
 
 
 

 

 

Item 8.01 Other Items

On January 8, 2024, NightHawk Biosciences, Inc. ( the “Company”) issued a press release announcing that it is changing the name of the Company to Scorpius Holdings, Inc., to better reflect the Company’s successful shift into a pure-play, large molecule biomanufacturing CDMO. The Company will continue to operate its CDMO within the Scorpius BioManufacturing, Inc. subsidiary. In connection with the name change, the Company’s ticker will change to SCPX. The Company has determined to effectuate the name change on January 22, 2024

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.  
       
  Exhibit
Number
  Description
   99.1   Press Release dated January 8, 2024 (Incorporated by reference as Exhibit 99.1 to Form 8-K filed with the Securities and Exchange Commission on January 8, 2024)
  104   Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

 

 

 

 

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated:  January 11, 2024

NightHawk Biosciences, Inc.

   
     
  By: /s/ Jeff Wolf
  Name:

Jeff Wolf

  Title: Chief Executive Officer

 

 

 

v3.23.4
Cover
Jan. 08, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 08, 2024
Entity File Number 001-35994
Entity Registrant Name NightHawk Biosciences, Inc.
Entity Central Index Key 0001476963
Entity Tax Identification Number 26-2844103
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 627 Davis Drive
Entity Address, Address Line Two Suite 300
Entity Address, City or Town Morrisville
Entity Address, State or Province NC
Entity Address, Postal Zip Code 27560
City Area Code (919)
Local Phone Number 240-7133
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member]  
Common Stock Common Stock, $0.0002 par value per share
Trading Symbol NHWK
Security Exchange Name NYSEAMER
Common Stock Purchase Rights [Member]  
Common Stock Common Stock Purchase Rights
Trading Symbol None
Security Exchange Name NYSEAMER

Nighthawk Biosciences (AMEX:NHWK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Nighthawk Biosciences Charts.
Nighthawk Biosciences (AMEX:NHWK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Nighthawk Biosciences Charts.